Clopidogrel 75mg tablets — a WHO Essential Medicines List antiplatelet (P2Y12 inhibitor) for the reduction of atherothrombotic events: recen
Clopidogrel 75mg tablets — a WHO Essential Medicines List antiplatelet (P2Y12 inhibitor) for the reduction of atherothrombotic events: recent myocardial infarction, recent ischemic stroke and established peripheral arterial disease. GMP manufactured by Artemisine Medicines Technology with full registration documentation for global tenders and private markets.
| Product Name | Clopidogrel Tablets 75mg |
|---|---|
| Dosage Form | Tablets |
| Strength | 75 mg |
| Standards | BP / ENTERPRISE |
| Packing | 10×2 blister (20 tablets per box) |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Every batch of Clopidogrel Tablets 75mg ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.
MOQ and lead time for Clopidogrel Tablets 75mg depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.
Yes. We offer OEM packaging and private-label production for Clopidogrel Tablets 75mg, subject to the regulatory requirements of the destination market.
We have supplied tablets products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.
Clopidogrel Tablets 75mg is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.
Artemisine Medicines